Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Immunome Inc (NASDAQ: IMNM) was $10.87 for the day, down -4.90% from the previous closing price of $11.43. In other words, the price has decreased by -$4.90 from its previous closing price. On the day, 0.87 million shares were traded. IMNM stock price reached its highest trading level at $11.55 during the session, while it also had its lowest trading level at $10.8375.
Ratios:
Our analysis of IMNM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.17 and its Current Ratio is at 6.17. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Overweight rating and assigned the stock a target price of $30.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.
On April 30, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $24.JP Morgan initiated its Overweight rating on April 30, 2024, with a $24 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 31 ’25 when SIEGALL CLAY B bought 150,000 shares for $7.75 per share. The transaction valued at 1,162,500 led to the insider holds 669,636 shares of the business.
SIEGALL CLAY B bought 66,057 shares of IMNM for $630,263 on Nov 21 ’24. The President and CEO now owns 485,693 shares after completing the transaction at $9.54 per share. On Nov 22 ’24, another insider, SIEGALL CLAY B, who serves as the President and CEO of the company, bought 33,943 shares for $9.78 each. As a result, the insider paid 331,918 and bolstered with 519,636 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 920416128 and an Enterprise Value of 438341120. For the stock, the TTM Price-to-Sale (P/S) ratio is 90.86 while its Price-to-Book (P/B) ratio in mrq is 3.06. Its current Enterprise Value per Revenue stands at 43.276 whereas that against EBITDA is -3.969.
Stock Price History:
The Beta on a monthly basis for IMNM is 1.90, which has changed by -0.5364605 over the last 52 weeks, in comparison to a change of 0.19995654 over the same period for the S&P500. Over the past 52 weeks, IMNM has reached a high of $30.96, while it has fallen to a 52-week low of $8.97. The 50-Day Moving Average of the stock is -4.29%, while the 200-Day Moving Average is calculated to be -16.95%.
Shares Statistics:
IMNM traded an average of 984.45K shares per day over the past three months and 1481940 shares per day over the past ten days. A total of 84.67M shares are outstanding, with a floating share count of 69.73M. Insiders hold about 15.31% of the company’s shares, while institutions hold 64.99% stake in the company. Shares short for IMNM as of 1736899200 were 10544273 with a Short Ratio of 10.71, compared to 1734048000 on 8800956. Therefore, it implies a Short% of Shares Outstanding of 10544273 and a Short% of Float of 17.83.
